Some countries release Novartis flu vaccines; Pharmalink, Patheon hook up on new drug;

> Canada and Switzerland have lifted their bans on Novartis ($NVS) flu vaccines saying they are satisifed with information they have received from the company. Story

> Sweden-based Pharmalink has signed a manufacturing contract with Patheon for Nefecon that is in development to address the pathology of IgA nephropathy. Story

> Officials in Tanzania have accused a manufacturer there of having produced counterfeit HIV medication. Story 

> Discovery Park, the site of a former Pfizer ($PFE) plant in the U.K., has been given Enterprise Zone status so it can provide cost incentives to help it attract the life science clients it is seeking. Story 

> Rite Aid ($RAD) reported a 1.1% drop in same-store sales in October as generic drug further captured more market share from branded products. Item

> Generics giant Teva Pharmaceutical Industries ($TEVA) displayed the flip side of the patent cliff phenomenon by reporting better than expected earnings today. Story 

And Finally... The FDA has announced a voluntary recall of Chinese bee pollen that contains undeclared Sibutramine, a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons. Release


Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.